Does Blue Cross Blue Shield of Minnesota Cover Ozempic?
The verdict
Conditional on most plans
BCBS of Minnesota covers Ozempic for type 2 diabetes with prior authorization as an independent BCBS affiliate in the competitive Minnesota market. It is not covered for off-label weight-loss use. Minnesota's permissive Medicaid GLP-1 obesity coverage (for on-label AOMs like Wegovy) does not extend to Ozempic under BCBS Minnesota commercial plans — these are separate coverage pathways. Formulary details not publicly confirmed at drug level — verify on BCBS MN drug lookup.
Coverage is set by your specific plan and formulary. This is a research summary — always confirm with Blue Cross Blue Shield of Minnesota using your member ID.
Key facts
Minnesota Medical Assistance (Medicaid) is one of a minority of state Medicaid programs that covers anti-obesity medications including Wegovy with PA — but this does not extend to Ozempic for off-label weight loss under any commercial BCBS Minnesota plan.
KFF, Medicaid Coverage of and Spending on GLP-1s, 2026
Ozempic is FDA-approved for type 2 diabetes glycemic control and cardiovascular risk reduction in T2D adults — not for weight loss. Off-label weight-loss use is not covered under any health plan.
FDA drug labeling, Ozempic (semaglutide injection)
The IRA Maximum Fair Price for semaglutide (Ozempic/Rybelsus/Wegovy) under Medicare is $274 per 30-day supply, effective January 1, 2027.
CMS, IRA Drug Price Negotiation Program, 2024
Medicare vs. commercial coverage
Whether Blue Cross Blue Shield of Minnesota covers Ozempic depends heavily on which kind of plan you hold. They follow completely different rules — here's each one, side by side.
Medicare
Part D & Advantage plans
Medicare Advantage: BCBS of Minnesota has limited Medicare Advantage presence; where available, Ozempic is covered for type 2 diabetes with prior authorization. The 2026 Part D $2,100 out-of-pocket cap limits annual beneficiary exposure. The IRA Maximum Fair Price for semaglutide is $274 per 30-day supply effective January 1, 2027. Medicare enrollees cannot use the NovoCare savings card (federal anti-kickback rules). Ozempic is not covered for weight loss on any Medicare Advantage plan — off-label weight-loss use is statutorily excluded from Medicare Part D.
Commercial / Employer
Group & marketplace plans
Commercial/Employer: BCBS of Minnesota covers Ozempic for type 2 diabetes with prior authorization and standard metformin step-therapy. BCBS MN competes in the Minnesota market with Medica, UCare, and HealthPartners. Formulary tier and copay are not publicly confirmed at the drug level — verify on BCBS MN's drug lookup. Not covered for off-label weight loss. Commercially insured T2D patients may be eligible for the NovoCare Ozempic Savings Card ($25 per fill, max $150/28-day supply); not available to Medicare or Medicaid enrollees. ACA/Individual: covered for T2D with PA; not covered for weight loss. Medicaid (Minnesota Medical Assistance): Minnesota Medicaid covers anti-obesity medications including Wegovy with PA — this is a state-level PDL decision for on-label weight-management drugs. It does not cover Ozempic for off-label weight loss; that distinction applies regardless of which managed-care plan administers the MN Medical Assistance benefit.
The 2 boxes you must tick to get approved
Commercial plans that will consider Ozempic require prior authorization. Check off what applies to you to see how close you are — this is a guide, not a guarantee of approval.
Meet all 2 and you have a documented case for approval. Missing any one is the most common reason requests are denied.
Your cost, three ways
What Ozempic actually costs you swings enormously depending on how it's covered. Here's the realistic range.
Paying cash
~$1,028/month (Novo Nordisk published pricing). NovoCare self-pay: ~$199/month intro (first two fills through December 31, 2026), then ~$349/month (0.25/0.5/1 mg) or ~$499/month (2 mg).
List price with no coverage — before any manufacturer savings card.
With coverage
Commercial/Employer: tier-based cost-share; specific tier and copay not publicly published — verify on BCBS MN's drug lookup. Medicare Advantage: cost-share per plan design; $2,100 OOP cap 2026; IRA Maximum Fair Price $274/30-day effective January 1, 2027. Minnesota Medical Assistance (Medicaid): nominal $0–$4 typical for covered T2D use.
Typical monthly copay once prior authorization is approved.
Bridge program
NovoCare Ozempic Savings Card: commercially insured T2D patients pay as little as $25 per fill (max $150 per 28-day supply). Not available to Medicare Advantage, Medicaid, VA, DoD, or TRICARE beneficiaries. Verify eligibility at NovoCare.com.
Reduced copay through the assistance program, where eligible.
All figures are estimates. Specific tier and cost-share for BCBS Minnesota commercial plans are not publicly confirmed at the drug level. Verify on BCBS MN's drug lookup or by calling member services.
Check YOUR exact coverage in 3 steps
General answers only get you so far. Here's how to confirm your own plan's decision in a few minutes.
- 1
Use BCBS Minnesota's drug lookup tool to confirm formulary status and PA requirements
Visit bluecrossmn.com and use the drug-lookup or formulary tool with your member ID to confirm Ozempic's tier, any prior-authorization requirements, and step-therapy criteria for your specific commercial or Medicare Advantage plan. Tier and copay are not published at the drug level in public documents.
- 2
Have your prescriber submit the prior authorization for type 2 diabetes
The PA requires a documented T2D diagnosis (ICD-10 E11.x) and evidence of metformin use (or a documented medical reason metformin is contraindicated or not tolerated). The clinical indication must be type 2 diabetes; a weight-management indication will not support PA approval under any BCBS Minnesota plan. If you have Minnesota Medicaid and are seeking weight-loss GLP-1 coverage, contact your Medical Assistance managed-care plan directly — that is a separate program from BCBS MN commercial.
- 3
Check NovoCare savings card eligibility if you have commercial coverage
If you have a BCBS Minnesota commercial or employer-sponsored plan and a confirmed T2D diagnosis, visit NovoCare.com to enroll in the Ozempic Savings Card, which may reduce your out-of-pocket cost to as little as $25 per fill (max $150/28-day supply). This card is not available to Medicare Advantage or Medicaid enrollees.
Options if Blue Cross Blue Shield of Minnesota won't cover Ozempic
A denial isn't the end of the road. These are the paths people commonly explore next — discuss any of them with your prescriber.
Rybelsus (oral semaglutide)
Oral semaglutide tablet approved for type 2 diabetes. Covered for T2D with PA on most plans; also subject to the IRA Maximum Fair Price of $274/30-day for Medicare patients effective January 1, 2027. Verify tier on BCBS MN's drug lookup.
Jardiance (empagliflozin)
SGLT-2 inhibitor commonly used as step therapy before or alongside Ozempic PA. Often available at a lower cost-share tier on BCBS commercial formularies.
Wegovy (semaglutide 2.4 mg) — via Minnesota Medical Assistance
For Minnesota Medicaid enrollees specifically: Minnesota Medical Assistance covers anti-obesity medications including Wegovy with PA. This is a state-level program for on-label weight management, separate from BCBS MN commercial coverage. Ozempic off-label for weight loss is not covered under this program. Contact your Medical Assistance managed-care plan for the AOM PA process.
Compounded semaglutide (weight-loss seekers only)
For commercially insured patients seeking semaglutide for weight management who are denied under BCBS MN, compounded semaglutide from $49/mo is available at getcurex.com/cl/glp without insurance. See the offer section below for full disclaimers.
These options are listed for information only — your own clinician decides what is appropriate for you.
❓Frequently Asked Questions
No. Blue Cross Blue Shield of Minnesota does not cover Ozempic for weight loss under any commercial, ACA, or Medicare Advantage line. Ozempic is FDA-approved for type 2 diabetes and cardiovascular risk reduction in T2D adults with known heart disease — not for weight management. Off-label weight-loss use is not a covered indication. Note: Minnesota Medicaid's broader GLP-1 obesity coverage applies to on-label weight-management drugs like Wegovy — not to Ozempic for off-label weight loss.
No. Minnesota Medical Assistance (Medicaid) covers anti-obesity medications including Wegovy with PA — but this applies only to on-label obesity drugs prescribed through the Medicaid AOM pathway. It does not create coverage for Ozempic off-label for weight loss, and it applies to Medicaid enrollees through state managed-care plans, not through BCBS Minnesota commercial or ACA plans. BCBS MN commercial members seeking weight-loss semaglutide coverage should check their employer benefit design for Wegovy coverage.
Yes. BCBS of Minnesota covers Ozempic for type 2 diabetes with prior authorization across its commercial, ACA, and Medicare Advantage lines. PA requires a documented T2D diagnosis and evidence of metformin step-therapy. Formulary tier and copay are not publicly confirmed at the drug level for BCBS MN's plans — verify on BCBS MN's drug lookup or by calling member services.
Yes, if you have a BCBS Minnesota commercial or employer-sponsored plan and a confirmed T2D diagnosis. The NovoCare Ozempic Savings Card may reduce your cost to as little as $25 per fill (max $150/28-day supply). The card is not available to Medicare Advantage or Medicaid enrollees — federal anti-kickback rules exclude government program beneficiaries. Verify current eligibility and terms at NovoCare.com.
BCBS of Minnesota, Medica, and UCare are all independent commercial insurers in the Minnesota market and all cover Ozempic for type 2 diabetes with prior authorization. The T2D-covered-with-PA pattern is consistent across all three. The key variable is each plan's specific tier placement and cost-share, which are not publicly published at the drug level for any of these regional plans. The most reliable approach is to use your insurer's own drug lookup tool to confirm your plan-specific cost-share before filling.
Related Articles
Does BCBS Michigan Cover Contrave? 2026 MI Guide | Curex
BCBS Michigan upheld weight-loss exclusions (DIFS 2025). Contrave is plan-dependent. MI Medicaid favors weight-loss GLP-1s; Contrave varies by PDL.
Read moreDoes BCBS of Illinois Cover Jardiance? 2026
BCBS of Illinois (HCSC) covers Jardiance across commercial, ACA, Medicare, and Medicaid. Metformin-first step is common. 2026 MFP $197 for Medicare.
Read moreDoes BCBS of Arizona Cover Wegovy? 2026 Guide | Curex
BCBS of Arizona covers Wegovy only where your employer opted in; formulary not published. Verify via drug-lookup and confirm with HR first.
Read moreDoes BCBS Alabama Cover Wegovy? 2026 Guide | Curex
BCBS Alabama Wegovy coverage is employer-dependent and unpublished. Alabama Medicaid excludes obesity GLP-1s. How to verify your specific plan.
Read moreDoes Blue Cross Blue Shield of Minnesota Cover Mounjaro? 2026 | Curex
BCBS of Minnesota covers Mounjaro for type 2 diabetes with PA — not weight loss. MN Medicaid covers weight-loss GLP-1s for Zepbound, not Mounjaro.
Read moreDoes BCBS of Texas Cover Ozempic? 2026 Guide | Curex
BCBS Texas (HCSC) covers Ozempic for T2D with PA — not weight loss. HCSC shares PA with BCBS IL. TX Medicaid uses separate Star MCOs. Verify on BCBS TX.
Read moreInsurance won't cover Ozempic for weight loss — here's a path that doesn't need it
BCBS of Minnesota does not cover Ozempic for weight loss. Even Minnesota's more permissive Medicaid GLP-1 coverage applies only to on-label obesity medications like Wegovy, not to Ozempic used off-label. For Minnesota patients seeking semaglutide for weight management, Curex offers compounded semaglutide from $49/mo at getcurex.com/cl/glp — no BCBS MN prior authorization required, no insurance needed. Compounded tirzepatide is also available from $149/mo. Compounded semaglutide is not the same medication as Ozempic or Wegovy. Prescription required, subject to provider review.
- Medication + free shipping
- 24/7 provider access
- Medical intake & prescription review
Compounded semaglutide and tirzepatide are not the same medications as Ozempic and are not branded or FDA-approved products. Compounded medications have not been approved by the FDA and the FDA has not evaluated their safety or efficacy.
This content is for informational purposes only and does not constitute medical, financial, or insurance advice. Coverage rules, prior-authorization criteria, and copay amounts change frequently and vary by plan, formulary tier, and effective date — always verify current benefits directly with Blue Cross Blue Shield of Minnesota before making any decision. Consult a licensed healthcare provider and your plan administrator for guidance specific to your situation. Curex offers compounded semaglutide and tirzepatide, which are not the same medications as Ozempic and are not branded or FDA-approved products; prescription required, subject to provider review. Compounded medications have not been approved by the FDA and the FDA has not evaluated their safety or efficacy.